The import of composite diagnostic or laboratory reagents into China is projected to grow steadily from 2024 to 2028, with the volume increasing from 13.518 million kilograms in 2024 to 14.938 million kilograms in 2028. Comparing these estimates to the 2023 figures, the Chinese market is demonstrating consistent growth, characterized by gradual year-on-year increases. This signifies China's rising demand for these essential reagents, reflecting growth in the healthcare and diagnostics sector.

Future trends to watch for include:

Advancements in diagnostic technology that might influence the composition and demand for reagents.
Policy changes related to healthcare that could impact import dynamics.
Potential shifts to domestic production as China enhances its capabilities in biotechnology and pharmaceuticals.